← Back to Clinical Trials
Recruiting NCT05719220

NCT05719220 Effect of Group Preoperative Pelvic Floor Training for HoLEP

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05719220
Status Recruiting
Phase
Sponsor University of California, San Francisco
Condition BPH
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2024-02-07
Primary Completion 2028-12-01

Eligibility & Interventions

Sex Male only
Min Age 50 Years
Max Age 90 Years
Study Type OBSERVATIONAL
Interventions
Group preoperative pelvic floor training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 100 participants in total. It began in 2024-02-07 with a primary completion date of 2028-12-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The main goal of this study is to see if group pelvic floor training before surgery can help prevent urinary incontinence after Holmium laser enucleation of the prostate (HoLEP) surgery. The study has the potential to inform preoperative intervention strategies for managing incontinence after HoLEP.

Eligibility Criteria

Inclusion Criteria: * Consecutive patients with a diagnosis of BPH with a plan to undergo HoLEP. * Between the age of 50-90. * Ability to understand and provide informed consent. Exclusion Criteria: * Patients whom inability to carry out PFT protocol. * Patients unwilling or unable to complete follow up care. * Severe urinary incontinence due to a history of neurological diseases such as a cerebrovascular accident or spinal cord injuries. * Patients whom inability to read and understand the English language.

Contact & Investigator

Central Contact

Victoria Hogue

✉ victoria.hogue@ucsf.edu

📞 415-302-7443

Principal Investigator

Max Bowman, M.D.

PRINCIPAL INVESTIGATOR

University of California, San Francisco

Frequently Asked Questions

Who can join the NCT05719220 clinical trial?

This trial is open to male participants only, aged 50 Years or older, up to 90 Years, studying BPH. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05719220 currently recruiting?

Yes, NCT05719220 is actively recruiting participants. Contact the research team at victoria.hogue@ucsf.edu for enrollment information.

Where is the NCT05719220 trial being conducted?

This trial is being conducted at San Francisco, United States.

Who is sponsoring the NCT05719220 clinical trial?

NCT05719220 is sponsored by University of California, San Francisco. The principal investigator is Max Bowman, M.D. at University of California, San Francisco. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology